|
US2017000784A1
|
|
Autophagy Inhibitors
|
|
CN105744937A
|
|
Highly potent glucocorticoids
|
|
US2014274768A1
|
|
Glycoforms of MUC5AC and Endorepellin and Biomarkers for Mucinous Pancreatic Cysts
|
|
WO2014130728A1
|
|
Norrin mutant polypeptides, methods of making and uses thereof
|
|
WO2013036936A1
|
|
Microrna biomarkers for diagnosing parkinson's disease
|
|
US2013045952A1
|
|
ABA Receptor Agonists for Increased Plant Stress Resistance
|
|
WO2012154879A2
|
|
Autophagy inhibitors
|
|
WO2011082321A1
|
|
Methods for diagnosing the malignant potential of pancreatic cystic lesions
|
|
WO2010129681A1
|
|
Methods for treating autophagy-related disorders
|
|
EP2411038A2
|
|
Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
|
|
WO2010083218A1
|
|
Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
|
|
US2009324603A1
|
|
Met fab and SCFV fragments
|
|
US2009138251A1
|
|
Bioinformatics research and analysis system and methods associated therewith
|
|
US2008131373A1
|
|
Fragments of antibodies to epidermal growth factor receptor and methods of their use
|
|
US2009053737A1
|
|
Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methods
|
|
WO2007147141A2
|
|
Methods for detecting molecular complexes
|
|
WO2007140410A2
|
|
Low-density lipoprotein receptor 6 (lrp6) as a mammary stem cell marker and related methods
|
|
WO2007134328A2
|
|
Geldanamycins and their quinone moieties inhibit cancer by acting on mitochondrial voltage-dependent anion channel (vdac) protein
|
|
AU2007200573A1
|
|
Anthrax lethal factor inhibits tumor growth and angiogenesis
|
|
US2007111265A1
|
|
Ligands for mineralocorticoid receptor (MR) and methods for screening for or designing MR ligands
|
